$47M grant aims to make Moffitt a hub for radiopharmaceutical cancer treatment

Josh Carpenter, president of Speros and chief integration officer at Moffitt Cancer Center, addresses a gathering to announce the awarding of a $47.3 million from the U.S. Economic Development Administration to establish a Southeastern U.S. hub for radiopharmaceutical innovation and manufacturing at the Pasco campus on Oct. 29, 2026. ( Moffitt Cancer Center)A Tampa Bay coalition has landed $47.3 million in federal funding to help establish the region as a national hub for developing and manufacturing radiopharmaceuticals, an emerging field of cancer treatment that the United States is looking to expand domestically.The investment will support five projects involving Moffitt Cancer Center, the University of South Florida, Embarc Collective and Pasco-Hernando State College. The effort is led by Moffitt and Speros, the cancer center's 775-acre life sciences campus in Land O' Lakes.ALSO READ: Moffitt opens Pasco research facility designed to accelerate development of cancer treatmentsThe r